FDA Places Clinical Hold on Concert Pharma ' s Hair Loss Drug FDA Places Clinical Hold on Concert Pharma ' s Hair Loss Drug
Concert Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration (FDA) imposed a clinical hold on a mid-stage trial testing the company ' s drug to treat alopecia areata.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pharmacist News Source Type: news
More News: Allergy | Allergy & Immunology | Alopecia | Alopecia Areata | Food and Drug Administration (FDA) | Pharmaceuticals